Ecabet
- Generic Name
- Ecabet
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C20H28O5S
- CAS Number
- 33159-27-2
- Unique Ingredient Identifier
- 2K02669KWP
- Background
Ecabet is a prescription eye drop for the treatment of dry eye syndrome. Ecabet represents a new class of molecules that increases the quantity and quality of mucin produced by conjunctival goblet cells and corneal epithelia. Mucin is a glycoprotein component of tear film that lubricates while retarding moisture loss from tear evaporation. Ecabet is currently marketed in Japan as an oral agent for treatment of gastric ulcers and gastritis.
- Indication
1.用于下列症状的胃粘膜损伤(糜烂、出血、红肿、水肿)，急性胃炎、慢性胃炎的急性发作期。
2.用于胃溃疡。
- Associated Conditions
- -
- Associated Therapies
- -
Efficacy of Ecabet Sodium and Proton Pump Inhibitor Combination Therapy in the Treatment of Iatrogenic Ulcer After Endoscopic Submucosal Dissection
- First Posted Date
- 2011-03-03
- Last Posted Date
- 2011-03-03
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 90
- Registration Number
- NCT01308177
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Efficacy and Safety Study for Ecabet Ophthalmic Solution for Treating Dry Eye Syndrome
- First Posted Date
- 2006-09-01
- Last Posted Date
- 2013-03-15
- Lead Sponsor
- Bausch & Lomb Incorporated
- Target Recruit Count
- 162
- Registration Number
- NCT00370747
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath